FDA inspection
Badrivishal Chemicals & Pharmaceuticals: FDA inspection ending Aug 19, 2016
FDA inspection 986230 · Official Action Indicated (OAI) · Dist. Pune
Key facts
| Inspection ID | 986230 |
|---|---|
| Firm | Badrivishal Chemicals & Pharmaceuticals |
| FEI number | 3004058356 |
| Address | Gat No. 29, Village Jambwade (Induri), Post Sudumbre, Taluka Maval |
| City | Dist. Pune |
| Country | India |
| Fiscal year | 2016 |
| Inspection end date | Aug 19, 2016 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 511820 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data